{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:30:43Z","timestamp":1780731043928,"version":"3.54.1"},"reference-count":24,"publisher":"Wiley","issue":"3-4","license":[{"start":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T00:00:00Z","timestamp":1368057600000},"content-version":"vor","delay-in-days":7514,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Rep Immunol"],"published-print":{"date-parts":[[1992,10,12]]},"abstract":"<jats:p><jats:bold>ABSTRACT: <\/jats:bold> The course of pregnancy in patients with systemic lupus erythematosus is not known. The Hopkins Lupus Pregnancy Center has followed 64 patients (74 pregnancies) prospectively since 1987. Patients are seen monthly and clinical and pregnancy\u2010related data collected, with particular emphasis on the occurrence of lupus flare. Flare rate during pregnancy was 1.63 per person\u2010year, compared to 0.64\u20100.65 after delivery or in non\u2010pregnant patients. Flare did not influence pregnancy outcome. Low serum C3 or C4 and high anticardiolipin antibody predicted pregnancy loss, and prednisone dose, aspirin use, diastolic second trimester blood pressure, C3 at first visit, and race predicted preterm birth. Maternal flare and preterm birth are important risks in lupus pregnancy. The latter can be predicted from maternal pregnancy data.<\/jats:p>","DOI":"10.1111\/j.1600-0897.1992.tb00788.x","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T11:38:20Z","timestamp":1368099500000},"page":"188-191","source":"Crossref","is-referenced-by-count":59,"title":["The Hopkins Lupus Pregnancy Center: 1987\u20131991 Update"],"prefix":"10.1111","volume":"28","author":[{"given":"MICHELLE","family":"PETRI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DENISE","family":"HOWARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN","family":"REPKE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIEL W.","family":"GOLDMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,5,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780341210"},{"key":"e_1_2_1_3_2","first-page":"37","article-title":"Problems associated with the management of pregnancies in patients with systemic lupus erythematosus","volume":"7","author":"Zulman JI","year":"1980","journal-title":"J Rheumatol"},{"key":"e_1_2_1_4_2","first-page":"252","article-title":"Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy","volume":"14","author":"Meehan RT","year":"1987","journal-title":"J Rheumatol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90538-2"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320602"},{"key":"e_1_2_1_7_2","first-page":"259","article-title":"Antibody to cardiolipin, lupus anticoagulant, and fetal death","volume":"14","author":"Lockshin MD","year":"1987","journal-title":"J Rheumatol"},{"key":"e_1_2_1_8_2","first-page":"525","article-title":"Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus","volume":"255","author":"Loizou S","year":"1988","journal-title":"Q J Med"},{"key":"e_1_2_1_9_2","first-page":"771","article-title":"Systemic lupus erythematosus. IV. Analysis of the interrelationship with pregnancy","volume":"17","author":"Nossent JC","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340802"},{"key":"e_1_2_1_12_2","first-page":"604","article-title":"Cross\u2010cultural validation and reliability of three disease activity indices in SLE","volume":"19","author":"Gladman DD","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_1_13_2","first-page":"1823","article-title":"The automated modified Russell viper venom time test for the lupus anticoagulant","volume":"18","author":"Petri M","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-4-524"},{"key":"e_1_2_1_15_2","volume-title":"Essentials of Medical Statistics","author":"Kirkwood R","year":"1988"},{"key":"e_1_2_1_16_2","article-title":"Fetal outcome of lupus pregnancy: A retrospective case\u2010control study of the Hopkins Lupus Cohort","author":"Petri M","year":"1992","journal-title":"J Rheumatol."},{"key":"e_1_2_1_17_2","first-page":"482","article-title":"Primary antiphospholipid syndrome","volume":"16","author":"Alarc\u00f3n\u2010Segovia D","year":"1989","journal-title":"J Rheumatol"},{"issue":"9","key":"e_1_2_1_18_2","first-page":"S163","article-title":"Hyperprolactinemia accelerates disease activity in the male NZB\/W mouse model of SLE (abstr)","volume":"34","author":"McMurray RW","year":"1991","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(91)90028-X"},{"issue":"9","key":"e_1_2_1_20_2","first-page":"S163","article-title":"Postpartum (PP) disease activity in the female B\/W mouse model of SLE (abstr)","volume":"34","author":"McMurray RW","year":"1991","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1542\/peds.77.4.582","article-title":"Outcome in infants born to mothers with unexplained elevations of maternal serum a\u2010fetoprotein","volume":"77","author":"Burton BK","year":"1986","journal-title":"Pediatrics"},{"key":"e_1_2_1_22_2","first-page":"72","article-title":"Alpha\u2010fetoprotein in obstetrics: Experience of a prenatal diagnosis center","volume":"33","author":"Cariati E","year":"1989","journal-title":"J Nucl Med Allied Sci"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(12)90749-8"},{"key":"e_1_2_1_24_2","first-page":"511","article-title":"Elevated maternal serum \u03b1\u2010fetoprotein values. How low is high?","volume":"34","author":"Lenke RR","year":"1989","journal-title":"J Reprod Med"},{"key":"e_1_2_1_25_2","first-page":"77","article-title":"Raised maternal plasma alpha\u2010fetoprotein and pregnancy outcome","volume":"33","author":"Strigini F","year":"1989","journal-title":"J Nucl Med Allied Sci"}],"container-title":["American Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0897.1992.tb00788.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0897.1992.tb00788.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T09:31:54Z","timestamp":1693387914000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0897.1992.tb00788.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,10,12]]},"references-count":24,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1992,10,12]]}},"alternative-id":["10.1111\/j.1600-0897.1992.tb00788.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0897.1992.tb00788.x","archive":["Portico"],"relation":{},"ISSN":["1046-7408","1600-0897"],"issn-type":[{"value":"1046-7408","type":"print"},{"value":"1600-0897","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,10,12]]}}}